|
⚲
|
| Message |
|---|
| Happy Holidays!! thanks for using AUM13F!! |
| Propel Bio Management LLC
✚
|
|
|---|---|
| CRD # | 322858 |
| SEC # | 801-126889 |
| CIK # | 0001969764 |
| AUM | $131.4 M (2025-03-25) |
| Employees | 7 (86% Investors, 0% Brokers) |
| Phone | 206-602-9246 |
| Address | 11620 Wilshire Blvd Los Angeles, CA 90025 |
| Source | [IAPD] [EDGAR] [Website] [LinkedIn] |
| Total AUM ($M) |
|---|
| Sector | Form 13F Holdings | Value ($M) | |
|---|---|---|---|
| Plains GP Holdings LP | 24.7 | ||
| Oncogenex Pharmaceuticals Inc | 13.9 | ||
| Akero Therapeutics Inc | 12.2 | ||
| Phathom Pharmaceuticals Inc | 8.9 | ||
| Access Pharmaceuticals Inc | 5.5 | ||
| Applied Therapeutics Inc | 3.5 | ||
| Milestone Pharmaceuticals Inc | 3.5 | ||
| Delcath Systems Inc | 3.1 | ||
| TScan Therapeutics Inc | 3.0 | ||
| Kempharm Inc | 2.0 | ||
| View All | |||
| Holdings by Sector ($M) |
|---|
| Type | Form D Funds | Date | Sold ($M) | AUM ($M) |
|---|---|---|---|---|
| Other | Propel Bio SPV 3 LLC | 2025-03-25 | 19.2 | |
| Other | PB SPV-1 LLC | 2024-07-09 | 2.5 | |
| Other | Propel Bio SPV 2 LLC | [2024-03-25] | 8.8 | 2.5 |
| VC | Propel Bio Partners LP | [2022-10-17] | 39.0 | 31.6 |
| AUM Breakdown | Accounts | AUM ($M) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 1 | 71.3 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 4 | 60.0 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 5 | 131.4 |
| By Discretionary | ||
| Discretionary | 5 | 131.4 |
| Non-Discretionary | 0 | 0.0 |
| Total | 5 | 131.4 |
| By Non-United States Persons | ||
| Non-United States Persons | 0.0 | |
| United States Persons | 131.4 | |
| Total | 5 | 131.4 |
| Form D Directors | # Filings | # Firms | 2011 - 2025 |
|---|---|---|---|
| Leen Kawas | 5 | ||
| Propel Bio Management | 2 | ||
| A Delaware Limited Liability Company Pbp Partners LLC | 1 |
| EDGAR Form | CIK | 2011 - 2025 |
|---|---|---|
| 13F-HR | [0001969764] | |
| SC 13D | [0001969764] | |
| SC 13G | [0001969764] |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Sygnus Capital PR LLC
✚
|
PR | 0.1 |
|
Onefund LLC
✚
|
FL | 0.1 |
|
Solpacific LLC
✚
|
MN | 0.1 |
|
Harmont Fixed Income LLC
✚
|
0.1 | |
|
Profit Investment Management LLC
✚
|
MD | 0.1 |
|
Highbury Park LLC
✚
|
0.1 | |
|
Change Finance PBC
✚
|
0.1 | |
|
Brickell Key Asset Management LLC
✚
|
SC | 0.1 |
|
WisdomTree Digital Management Inc
✚
|
NY | 0.1 |
|
SRN Advisors LLC
✚
|
PA | 0.1 |